Head of Research, IPOs & Placements, Aequitas Research

Sumeet Singh

Head of IPO & Placements for Aequitas Research. At Aequitas we cover all IPOs and placements across Asia-Pac with a deal size of at least US$100m. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%. 
Prior to Aequitas. I was heading Content Strategy for Smartkarma, along with covering IPOs & Placement. In an earlier life I have covered ASEAN property and the banking space in India.

Head of Research, IPOs & Placements

IHH Placement: Past Deal Did OK, Earning Hiccup but Prospects Remain Intact

IHH: Asian Health-Care Demand to Spur Major Gains

Parkway Pantai: Good Brand with Limited Upside

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Capital Markets

<p>Khazanah plans to raise US$200m by selling down 1.6% of IHH Healthcare at a tight 0-1.5% discount. </p><p>The deal scores a mixed score on our framework with its track record holding it in good stead while its largest shareholder selling down adds to the negatives. We note that Khazanah has been selling in bits and pieces ever since IHH listed in 2012, there has been news off late of Khazanah wanting to trim its holding further. However, the discount is tight while the stock is trading near its 52-week…</p>

Khazanah plans to raise US$200m by selling down 1.6% of IHH Healthcare at a tight 0-1.5% discount. The deal scores a mixed score on our framework with its track record holding it in good stead while its largest shareholder selling down adds to the negatives. We note that Khazanah has been selling in bits and pieces ever since IHH listed in 2012, there has been news off late of Khazanah wanting to trim its holding further. However, the discount is tight while the stock is trading near its 52-week…

IHH Healthcare

IHH Healthcare - No Surprises